Health Care [ 6/12 ] | Biotechnology [ 45/74 ]
NASDAQ | Common Stock
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases.
The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 31, 22 | -0.30 Decreased by -492.89% | - |
| Jun 2, 22 | -0.29 Decreased by -1.64 K% | - |
| Oct 29, 21 | -0.11 Decreased by -558.68% | - |
| Apr 26, 21 | -29.80 Decreased by -115.85 K% | - |
| Mar 31, 21 | -0.05 Decreased by -96.89% | - |
| Dec 31, 20 | -0.02 Decreased by -12.08% | - |
| Sep 30, 20 | -0.02 Decreased by -12.08% | - |
| Jun 30, 20 | -0.03 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 22 | -2.34 B Increased by 0.00% | -7.66 B Decreased by -11.64 K% | Increased by +327.03% Increased by +11.64 K% |
| Jun 30, 22 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Mar 31, 22 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Dec 31, 21 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Sep 30, 21 | -2.34 B Decreased by N/A% | -65.25 M Decreased by N/A% | Increased by +2.79% - |
| Jun 30, 21 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Mar 31, 21 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Dec 31, 20 | N/A Decreased by -100.00% | N/A Decreased by -100.00% | - - |